Cited by 134Osteoarthritis Treatment and MechanismsProteoglycans and glycosaminoglycans researchHip disorders and treatments

Gene expression in human chondrocytes in late osteoarthritis is changed in both fibrillated and intact cartilage without evidence of generalised chondrocyte hypertrophy

Brew, C J, Clegg, P D, Boot-Handford, R P, Andrew, J G, Hardingham, T·2010·Annals of the Rheumatic Diseases

Abstract

Objectives To investigate changes in gene expression in fibrillated and intact human osteoarthritis (OA) cartilage for evidence of an altered chondrocyte phenotype and hypertrophy.Methods Paired osteochondral samples were taken from a high-load site and a low-load site from 25 OA joints and were compared with eight similar paired samples from age-matched controls. Gene expression of key matrix and regulatory genes was analysed by quantitative real-time reverse transcription-polymerase chain reaction on total RNA extracted from the cartilage.Results There was a major change in chondrocyte gene expression in OA cartilage. SOX9 (38-fold) and aggrecan (4-fold) gene expression were both lower in OA (p<0.001), and collagen I (17-fold) and II (2.5-fold) gene expression were each increased in a subset of OA samples. The major changes in gene expression were similar at the fibrillated high-loaded site and the intact low-loaded site. There was no evidence of a generalised change in OA to proliferative or hypertrophic phenotype as seen in the growth plate, as genes associated with either stage of differentiation were unchanged (PTHrPR), or significantly downregulated (collagen X (14-fold, p<0.002), VEGF (23-fold, p<0.02), BCL-2 (5.6-fold, p<0.001), matrilin-1 (6.5-fold, p<0.001)). In contrast MMP-13 was significantly upregulated in the OA cartilage samples (5.3-fold, p<0.003).Conclusions The expression of key chondrocyte genes, including aggrecan and SOX9, was decreased in OA cartilage and the changes were similar in both fibrillated high-loaded and intact low-loaded cartilage on the same joint. However, there was no significant upregulation of type X collagen, and other genes associated with chondrocyte further differentiation and hypertrophy.

Integrity signals

Registry

Crossref · 10.1136/ard.2008.097139

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Brew, C. J., Clegg, P. D., Boot-Handford, R. P., Andrew, J. G., & Hardingham, T.
Affiliations
  • Wellcome Centre for Cell-Matrix Research (GB)
  • University of Liverpool (GB)
  • Ysbyty Gwynedd Hospital NHS Trust (GB)
Corresponding author
Clegg, P D
Venue
Annals of the Rheumatic Diseases
Publisher
Elsevier BV
Published
2010-01
Volume
69
Issue
1
Pages
234-240
ISSN
0003-4967 (ISSN-L)
OpenAlex
W2160964180
Cited by
134
References
48
Citations by year
2025: 4 · 2024: 5 · 2023: 5 · 2022: 4 · 2021: 12 · 2020: 3 · 2019: 10 · 2018: 6 · 2017: 7 · 2016: 10 · 2015: 8 · 2014: 11 · 2013: 7 · 2012: 16
FWCI
5.98
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of the Rheumatic Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
Funders
  • Wellcome Trust
  • Biotechnology and Biological Sciences Research Council
Topics
  • Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
  • Health Sciences › Medicine › Surgery › Hip disorders and treatments
Keywords
osteoarthritis, chondrocyte gene expression, cartilage, chondrocyte hypertrophy, SOX9, aggrecan, type II collagen, type I collagen, MMP-13, type X collagen
MeSH terms
Aged, Aged, 80 and over, Cartilage, Articular, Collagen, Female, Gene Expression Regulation, Humans, Hypertrophy, Knee Joint, Male, Middle Aged, RNA, Messenger, Weight-Bearing, Chondrocytes, Osteoarthritis, Knee, Gene Expression Profiling, Aggrecans, SOX9 Transcription Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review